Gastric Antral Vascular Ectasia disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: GST020 MIFTS: 37	Gastric Antral Vascular Ectasia Categories: Rare diseases, Cardiovascular diseases, Gastrointestinal diseases
Genes Tissues Related diseases Publications Drugs Download Expand all tables

Sources

Aliases & Classifications for Gastric Antral Vascular Ectasia

MalaCards integrated aliases for Gastric Antral Vascular Ectasia:

Name: Gastric Antral Vascular Ectasia ¹² ⁵³ ⁴⁴ ¹⁵

Watermelon Stomach ¹² ⁷⁶ ⁵³

Gave ⁵³

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Cardiovascular diseases Gastrointestinal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:2493

MeSH ⁴⁴ D020252

NCIt ⁵⁰ C84724

SNOMED-CT ⁶⁸ 412795008 43935004

UMLS ⁷³ C0267211

Sources

Summaries for Gastric Antral Vascular Ectasia

NIH Rare Diseases : ⁵³ Watermelon stomach is a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy. Although it can develop in men and women of all ages, watermelon stomach is most commonly observed in older women (over age 70 years). Signs and symptoms of watermelon stomach include blood in the stool, hematemesis (vomiting blood) and anemia. The exact cause of watermelon stomach is unknown; however, it is often diagnosed in people with other chronic (long-term) conditions such as cirrhosis (scarring of the liver and poor liver function), autoimmune disease, systemic sclerosis, and CREST syndrome. Treatment consists of surgery and/or medications to stop or control the bleeding.

MalaCards based summary : Gastric Antral Vascular Ectasia, also known as watermelon stomach, is related to duodenitis and portal hypertension. An important gene associated with Gastric Antral Vascular Ectasia is SST (Somatostatin). The drugs Proton Pump Inhibitors and Iron have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and myeloid.

Wikipedia : ⁷⁶ Gastric antral vascular ectasia (GAVE) is an uncommon cause of chronic gastrointestinal bleeding or iron... more...

Sources

Related Diseases for Gastric Antral Vascular Ectasia

Diseases related to Gastric Antral Vascular Ectasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 94)

#	Related Disease	Score	Top Affiliating Genes
1	duodenitis	30.4	ATP12A ATP4A
2	portal hypertension	29.9	CTC1 SST
3	transcobalamin ii deficiency	11.0
4	campomelic dysplasia	10.8
5	hyperlipidemia, familial combined	10.8
6	marfan syndrome	10.8
7	pseudo-von willebrand disease	10.8
8	spherocytosis, type 1	10.8
9	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1	10.8
10	smith-lemli-opitz syndrome	10.8
11	ichthyosis, x-linked	10.8
12	sacral defect with anterior meningocele	10.8
13	agammaglobulinemia 1, autosomal recessive	10.8
14	scleroderma, familial progressive	10.6
15	fungal esophagitis	10.3	ATP12A ATP4A
16	bladder calculus	10.3	ATP12A ATP4A
17	neonatal candidiasis	10.3	ATP12A ATP4A
18	photoallergic dermatitis	10.3	ATP12A ATP4A
19	squamous papillomatosis	10.3	ATP12A ATP4A
20	acute laryngitis	10.3	ATP12A ATP4A
21	gastroduodenal crohn's disease	10.3	ATP12A ATP4A
22	toxic megacolon	10.3	ATP12A ATP4A
23	aspiration pneumonitis	10.3	ATP12A ATP4A
24	postsurgical hypothyroidism	10.3	ATP12A ATP4A
25	esophageal candidiasis	10.3	ATP12A ATP4A
26	rumination disorder	10.3	ATP12A ATP4A
27	bile reflux	10.3	ATP12A ATP4A
28	granulomatous gastritis	10.3	ATP12A ATP4A
29	active peptic ulcer disease	10.3	ATP12A ATP4A
30	laryngeal disease	10.3	ATP12A ATP4A
31	ischemic neuropathy	10.3	ATP12A ATP4A
32	capillary disease	10.3	ATP12A ATP4A
33	peptic esophagitis	10.3	ATP12A ATP4A
34	duodenal disease	10.3	ATP12A ATP4A
35	hernia, hiatus	10.3	ATP12A ATP4A
36	congenital disorder of deglycosylation	10.2	ATP12A ATP4A
37	anismus	10.2	ATP12A ATP4A
38	esophageal atresia/tracheoesophageal fistula	10.2	ATP12A ATP4A
39	laryngitis	10.2	ATP12A ATP4A
40	laryngeal tuberculosis	10.2	ATP12A ATP4A
41	lymphocytic colitis	10.2	ATP12A ATP4A
42	clostridium difficile colitis	10.2	ATP12A ATP4A
43	lower urinary tract calculus	10.2	ATP12A ATP4A
44	aspiration pneumonia	10.2	ATP12A ATP4A
45	diarrhea 1, secretory chloride, congenital	10.2	ATP12A ATP4A
46	chronic laryngitis	10.2	ATP12A ATP4A
47	chronic intestinal vascular insufficiency	10.2	ATP12A ATP4A
48	eosinophilic gastritis	10.2	ATP12A ATP4A
49	polyposis, skin pigmentation, alopecia, and fingernail changes	10.2	ATP12A ATP4A
50	esophagus adenocarcinoma	10.1	ATP12A ATP4A

Graphical network of the top 20 diseases related to Gastric Antral Vascular Ectasia:

Sources

Symptoms & Phenotypes for Gastric Antral Vascular Ectasia

Sources

Drugs & Therapeutics for Gastric Antral Vascular Ectasia

Drugs for Gastric Antral Vascular Ectasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 22)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Proton Pump Inhibitors

Phase 2, Phase 3

Iron

Approved

Phase 2,Not Applicable

7439-89-6

23925

Synonyms:

02583_FLUKA

12310_ALDRICH

12310_RIEDEL

129048-51-7

14067-02-8

161135-39-3

190454-13-8

195161-83-2

199281-22-6

209309_ALDRICH

209309_SIAL

255637_ALDRICH

266213_ALDRICH

266256_ALDRICH

267945_ALDRICH

267953_ALDRICH

26Fe

338141_ALDRICH

356808_ALDRICH

356824_ALDRICH

356832_ALDRICH

39344-71-3

3ZhP

413054_ALDRICH

443783-52-6

44890_ALDRICH

44890_FLUKA

675141-17-0

70884-35-4

73135-38-3

7439-89-6

8011-79-8

8053-60-9

AC1L2N38

Ancor B

Ancor en 80/150

armco Iron

Armco iron

Atomel 28

Atomel 300M200

Atomel 500M

Atomel 95

Atomiron 44MR

Atomiron 5M

Atomiron AFP 25

Atomiron AFP 5

ATW 230

ATW 432

C00023

C3518_SIAL

C3518_SIGMA

Carbonyl iron

CCRIS 1580

CHEBI:18248

CID23925

Copy Powder CS 105-175

D007501

DB01592

Diseases (animal), iron overload

Diseases, iron overload

DSP 1000

DSP 128B

DSP 135

DSP 135C

DSP 138

Ed-In-Sol

EF 1000

EF 250

EFV 200/300

EFV 250

EFV 250/400

EINECS 231-096-4

Eisen

Electrolytic iron

F 60 (metal)

FE (II) ion

Fe(2+)

Fe(II)

Fe1+

Fe-40

fer

Feronate

Ferretts

Ferro-Caps

Ferro-Time

Ferrous ion

ferrous iron

Ferrousal

Ferrovac e

Ferrovac E

Ferrum

Ferrum metallicum

FT 3 (element)

GS 6

Hematite

Hemocyte

HF 2 (element)

hierro

Hierro

HL (iron)

Hoeganaes ATW 230

Hoeganaes EH

HQ (metal)

HS (iron)

HS 4849

HSDB 604

Infed

IRMM524A_FLUKA

IRMM524B_FLUKA

IRON

Iron (Fe)

Iron (Fe1+)

Iron ion (Fe+)

Iron ion(1+)

Iron ion(2+)

Iron monocation

Iron powder

Iron standard for AAS

Iron(1+)

Iron(1+) ion

Iron(III) nitrate solution

Iron, carbonyl

Iron, electrolytic

Iron, elemental

Iron, ion (Fe1+)

Iron, ion (Fe1+) (8CI,9CI)

Iron, reduced

Limonite

LOHA

LS-3196

Magnetite

Malleable iron

Metopirone

Metyrapone

MolPort-003-925-001

NC 100

PZh1M1

PZh-1M3

PZh-2

PZh2M

PZH2m

PZh2M1

PZh2M2

PZh3

PZh3M

PZh4M

PZhO

PZHO

Reduced iron

Remko

Siderol

Suy-b 2

SUY-B 2

Taconite

UNII-E1UOL152H7

Venofer

Vitedyn-Slo

Wrought iron

Yieronia

Angiogenesis Inhibitors

Phase 2

Angiogenesis Modulating Agents

Phase 2

Anti-Bacterial Agents

Phase 2

Anti-Infective Agents

Phase 2

Immunosuppressive Agents

Phase 2

Carvedilol

Approved, Investigational

Not Applicable

72956-09-3

2585

Synonyms:

(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol

(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol

(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol

(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol

1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol

1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol

1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol

1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol

107741-96-8

72956-09-3

AB1004830

AC-1641

AC1L1E0B

Artist

Artist (TN)

Atlana Pharma brand of carvedilol

Bio-0014

BM 14190

BM-14.190

BM-14190

BM-14-190

BRD-A10977446-001-04-8

BRD-A10977446-045-01-1

C043211

C06875

C2260

C24H26N2O4

carvedilol

Carvedilol

Carvedilol (JAN/USAN/INN)

Carvedilol [USAN:INN:BAN:JAN]

Carvedilol hydrochloride

carvedilol, (+-)-isomer

Carvedilol, (+-)-isomer

carvedilol, (R)-isomer

Carvedilol, (R)-isomer

carvedilol, (S)-isomer

Carvedilol, (S)-isomer

carvedilol, 14C-labeled

Carvedilol, 14C-labeled

Carvedilolum

Carvedilolum [Latin]

CHEBI:3441

CHEMBL723

CID2585

Coreg

Coreg (TN)

Coreg CR

Coropres

Coropress

CPD000449280

D00255

DB01136

Dibloc

Dilatrend

DQ 2466

DQ-2466

EG-P042

Eucardic

GlaxoSmithKline brand of carvedilol

HMS2051N03

HMS2089B09

HMS2093E12

HSDB 7044

I06-0064

I06-1477

KBio2_002145

KBio2_004713

KBio2_007281

KBio3_002323

KBioGR_001252

KBioSS_002145

Kredex

L001243

Lakeside brand of carvedilol

LS-121875

MLS000758299

MLS000759508

MLS001424092

MolPort-003-666-814

NCGC00167832-01

NCGC00167832-02

NCGC00167832-03

Querto

Roche brand of carvedilol

SAM001246736

SAM001247021

SK&F-105517

SKF 105517

SMR000449280

SPBio_001885

Spectrum_001665

Spectrum2_001673

Spectrum3_001182

Spectrum4_000636

Spectrum5_001436

STK621453

TL8005080

UNII-0K47UL67F2

Simvastatin

Approved

Not Applicable

79902-63-9

54454

Synonyms:

(+)-Simvastatin

(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate

2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester

2,2-Dimethylbutyrate, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one

2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one

2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one

79902-63-9

AC-1530

AC1L1H1F

AKOS005111006

ARONIS24119

BCBcMAP01_000007

BIDD:GT0769

Bio-0672

BPBio1_001001

BRD-K22134346-001-05-8

BRN 4768037

BSPBio_000909

BSPBio_002337

Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester

Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester

Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester

butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta

C25H38O5

CCRIS 7558

CHEBI:9150

CHEMBL1064

Cholestat

CID54454

Coledis

Colemin

Corolin

CPD000718785

D00434

D019821

Denan

DivK1c_006991

DRG-0320

Eucor

HMS1570N11

HMS1922H13

HMS2089D12

HMS2093E06

HSDB 7208

InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1

KBio1_001935

KBio2_002197

KBio2_004765

KBio2_007333

KBio3_001557

KBioGR_001244

KBioSS_002197

Kolestevan

KS-1113

L 644128-000U

Labistatin

Lipex

Lipinorm

Liponorm

Lipovas

Lodales

LS-46264

Medipo

MK 0733

MK 733

MK-0733

MK733

MK-733

MLS001304029

MLS001333077

MLS001333078

MLS002154038

Modutrol

MolPort-002-507-345

MolPort-002-885-862

NCGC00017324-01

NCGC00017324-02

NCGC00017324-03

nchembio790-comp16

Nivelipol

Nor-vastina

Pantok

Pepstatin

Prestwick_171

Prestwick0_000865

Prestwick1_000865

Prestwick2_000865

Prestwick3_000865

Rechol

Rendapid

S1792_Selleck

S6196_SIGMA

SAM002589969

Simcor

Simovil

Simvast CR

simvastatin

Simvastatin

Simvastatin & Primycin

Simvastatin (JAN/USP/INN)

Simvastatin [Usan:Ban:Inn]

Simvastatin [USAN:INN:BAN]

Simvastatin lactone

Simvastatin, Compactin

Simvastatina

Simvastatina [Spanish]

Simvastatine

Simvastatine [French]

Simvastatinum

Simvastatinum [Latin]

Simvotin

Sinvacor

Sinvascor

Sivastin

SMR000718785

SPBio_001881

SPBio_002830

SpecPlus_000895

Spectrum_001717

SPECTRUM1504236

Spectrum2_001671

Spectrum3_000669

Spectrum4_000632

Spectrum5_001428

Statin

STK801938

Synvinolin

TNP00259

UNII-AGG2FN16EV

Valemia

Vasotenal

Velostatin

Vytorin

ZINC03780893

Zocor

Zocor (TN)

Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin

Zocord

Adrenergic Agents

Not Applicable

Adrenergic alpha-1 Receptor Antagonists

Not Applicable

Adrenergic alpha-Antagonists

Not Applicable

Adrenergic Antagonists

Not Applicable

Adrenergic beta-Antagonists

Not Applicable

Anticholesteremic Agents

Not Applicable

Antihypertensive Agents

Not Applicable

Antimetabolites

Not Applicable

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Not Applicable

Hypolipidemic Agents

Not Applicable

Lipid Regulating Agents

Not Applicable

Neurotransmitter Agents

Not Applicable

Vasodilator Agents

Not Applicable

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial	Completed	NCT01601639	Phase 3
2	Cyrotherapy vs. APC in GAVE	Completed	NCT00587405	Phase 2, Phase 3
3	Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation	Completed	NCT00964496	Phase 2	Thalidomide;Iron
4	A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand	Recruiting	NCT03302858	Phase 2
5	To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.	Completed	NCT02465645	Not Applicable	Carvedilol;Carvedilol + Simvastatin
6	Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)	Recruiting	NCT03525366
7	Usefulness of Fecal Immunochemical Test in Iron Deficiency Anemia (IDAFIT)	Recruiting	NCT02792023	Not Applicable
8	Treatment of Ex-vivo Small Bowel Mucosa With a Dedicated Radiofrequency Ablation (SB-RFA) Catheter.	Withdrawn	NCT03320395	Not Applicable

Search NIH Clinical Center for Gastric Antral Vascular Ectasia

Cochrane evidence based reviews: gastric antral vascular ectasia

Sources

Genetic Tests for Gastric Antral Vascular Ectasia

Sources

Anatomical Context for Gastric Antral Vascular Ectasia

MalaCards organs/tissues related to Gastric Antral Vascular Ectasia:

⁴¹

Liver, Testes, Myeloid, Kidney

Sources

Publications for Gastric Antral Vascular Ectasia

Articles related to Gastric Antral Vascular Ectasia:

(show top 50) (show all 180)

#	Title	Authors	Year
1	Gastric Antral Vascular Ectasia: A Case Report and Literature Review. ( 29607305 )	Alkhormi A.M....Alqarawi A.	2018
2	Insights into the management of gastric antral vascular ectasia (watermelon stomach). ( 29399041 )	Hsu W.H....Wu D.C.	2018
3	Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome. ( 29961911 )	Smith E....Caldwell S.	2018
4	Radiofrequency ablation (RFA) vs. argon plasma coagulation (APC) for the management of gastric antral vascular ectasia (GAVE) in patients with and without cirrhosis: results from a retrospective analysis of a large cohort of patients treated at a single center. ( 29497685 )	St Romain P....Wild D.	2018
5	An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia. ( 29450749 )	Thomas A....Reuben A.	2018
6	Case series on multimodal endoscopic therapy for gastric antral vascular ectasia, a tertiary center experience. ( 29375739 )	Matin T....Peter S.	2018
7	Comparative Effectiveness and Safety of Radiofrequency Ablation Versus Argon Plasma Coagulation for Treatment of Gastric Antral Vascular Ectasia: A Systematic Review and Meta-Analysis. ( 29952856 )	McCarty T.R....Rustagi T.	2018
8	Gastric antral vascular ectasia presenting as a polypoid mass in a patient with cirrhosis. ( 28803743 )	Hudson C....Landreneau S.	2017
9	Gastric antral vascular ectasia and solitary rectal ulcer syndrome - two rare diagnoses as the cause of anemia in aA single patient: case report. ( 28726433 )	KunovskA1 L....Dolina J.	2017
10	Vascular-targeted photodynamic therapy of gastric antral vascular ectasia (GAVE). ( 27871022 )	Qiu H....Gu Y.	2017
11	Endoscopic Treatment for Gastric Antral Vascular Ectasia: Current Options. ( 29255747 )	Zepeda-GA^mez S.	2017
12	Nitrous oxide CryoBalloon therapy of refractory gastric antral vascular ectasia. ( 28679138 )	Trindade A.J....Sejpal D.V.	2017
13	Gastric Antral Vascular Ectasia and Metabolic Syndrome: Is There a Case for an Association? ( 29073974 )	Shoreibah M....Peter S.	2017
14	Gastric antral vascular ectasia in systemic sclerosis: Where do we stand? ( 28217887 )	El-Gendy H....Mahmoud M.	2017
15	Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation. ( 28690769 )	Garg S....Nickl N.	2017
16	Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature. ( 28835751 )	Maida M....Scarpulla G.	2017
17	Radiofrequency ablation using Barrx(Ar) for the endoscopic treatment of gastric antral vascular ectasia: a series of three cases and a review of the literature on treatment options. ( 28744150 )	Patel A....Vadada D.	2017
18	Radiofrequency ablation for gastric antral vascular ectasia and radiation proctitis. ( 28367587 )	Markos P....Rustemovic N.	2017
19	A Case of Gastric Antral Vascular Ectasia Which Was Aggravated by Acid Reducer. ( 28611555 )	Nakade Y....Yoneda M.	2017
20	Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center. ( 28520574 )	Allamneni C....Peter S.	2017
21	Hemorrhage from Extra-Antral Gastric Antral Vascular Ectasia in a Patient with Duodenal Heterotopic Gastric Mucosa. ( 27830096 )	Gubatan J....Berzin T.M.	2016
22	Gastric Antral Vascular Ectasia during the Treatment of Chronic Myelogenous Leukemia with Imatinib Mesylate. ( 26726089 )	Narukawa K....Ohashi K.	2016
23	Treating Gastric Antral Vascular Ectasia - When Argon Therapy Is Not Enough. ( 28868470 )	Dias de Castro F....Cotter J.	2016
24	Gastric antral vascular ectasia. ( 27728256 )	Nighute S....Shiddhapur G.S.	2016
25	Radiofrequency ablation of gastric antral vascular ectasia of the gastric cardia. ( 27669532 )	Trindade A.J....Magier D.	2016
26	Clinical Characterization of Gastric Antral Vascular Ectasia: A Potential Manifestation of the Metabolic Syndrome. ( 27476085 )	Smith E....Caldwell S.	2016
27	Endoscopic band ligation for gastric antral vascular ectasia: time for a new indication? ( 26820079 )	Marzano C....Traversa G.	2016
28	Radiofrequency ablation for treatment of refractory gastric antral vascular ectasia (with video). ( 26135652 )	Jana T....Ertan A.	2015
29	Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation. ( 25650636 )	Zepeda-GA^mez S....Montano-Loza A.J.	2015
30	Development of hyperplastic polyps following argon plasma coagulation of gastric antral vascular ectasia. ( 26283860 )	Shah N....Shaikh S.	2015
31	Radiofrequency ablation therapy - the grave for GAVE (gastric antral vascular ectasia)? ( 26135653 )	Peter S....Wilcox C.M.	2015
32	Portal hypertensive gastropathy and gastric antral vascular ectasia. ( 26376475 )	Han S....Wassef W.	2015
33	Intravenous cyclophosphamide as a therapeutic option for severe refractory gastric antral vascular ectasia in systemic sclerosis. ( 26429218 )	Papachristos D.A....Stevens W.M.	2015
34	Refractory gastric antral vascular ectasia: a new endoscopic approach. ( 26592837 )	Zulli C....Esposito P.	2015
35	Patients with Gastric Antral Vascular Ectasia (GAVE) Are at a Higher Risk of Gastrointestinal Bleeding in the Absence of Cirrhosis. ( 26807380 )	Wang J....Cohn S.M.	2015
36	Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia. ( 25729047 )	Bhattacharyya A....Moore J.	2015
37	Erythropoietin resistance in end-stage renal disease patient with gastric antral vascular ectasia. ( 26154650 )	Lee D.J....de GA^es M.A.8.	2015
38	Gastric Antral Vascular Ectasia (GAVE): An Overlooked Diagnosis. ( 25772970 )	Hanif M.O....Afzal R.	2015
39	Gastric Antral Vascular Ectasia in Systemic Sclerosis: Current Concepts. ( 26633973 )	Parrado R.H....Quintana LA^pez G.	2015
40	Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia. ( 25855138 )	Ohta S....Imamura J.	2015
41	Imatinib-induced gastric antral vascular ectasia in three patients with chronic myeloid leukaemia. ( 26134364 )	Ong J....Nandurkar H.	2015
42	Endoscopic radiofrequency ablation for APC refractory gastric antral vascular ectasia using the HALO90 system in a kidney transplant candidate. ( 25952805 )	IbA!A+ez-Sanz G....Gornals J.B.	2015
43	Portal hypertensive gastropathy and gastric antral vascular ectasia. ( 26564121 )	Garg H....Broor S.L.	2015
44	Erythropoietin resistance in end-stage renal disease patient with gastric antral vascular ectasia. ( 26398652 )	Lee D.J....GA^es M.A.8.	2015
45	Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia. ( 25987803 )	Becq A....Dray X.	2015
46	Microvascular architecture in a case of gastric antral vascular ectasia (watermelon stomach). ( 24594964 )	Kern S.E....Sitzmann J.V.	2014
47	Radiofrequency Ablation of Treatment-refractory Gastric Antral Vascular Ectasia (GAVE). ( 24743681 )	Raza N....Diehl D.L.	2014
48	Gastric antral vascular ectasia unresponsive to endoscopic treatment requiring antrectomy. ( 25240797 )	Frasconi C....Perrin H.	2014
49	Watermelon stomach: gastric antral vascular ectasia. ( 25475404 )	Shimamura Y....Takizawa H.	2014
50	Gastric Antral Vascular Ectasia. ( 26259325 )	Basavaraj A....Kadam D.B.	2014

Sources

Genes for Gastric Antral Vascular Ectasia

Genes related to Gastric Antral Vascular Ectasia (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	SST	Somatostatin	Protein Coding	20.87	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
2	ATP12A	ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit	Protein Coding	15.68	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
3	ATP4A	ATPase H+/K+ Transporting Subunit Alpha	Protein Coding	15.68	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
4	CTC1	CST Telomere Replication Complex Component 1	Protein Coding	15.47	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
5	OXCT1	3-Oxoacid CoA-Transferase 1	Protein Coding	15.2	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
6	UBTF	Upstream Binding Transcription Factor	Protein Coding	15.16	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)

Sources

Variations for Gastric Antral Vascular Ectasia

Sources

Expression for Gastric Antral Vascular Ectasia

Search GEO for disease gene expression data for Gastric Antral Vascular Ectasia.

Sources

Pathways for Gastric Antral Vascular Ectasia

Sources

GO Terms for Gastric Antral Vascular Ectasia

Biological processes related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	sodium ion transport	GO:0006814	9.43	ATP12A ATP4A
2	response to nutrient	GO:0007584	9.4	OXCT1 SST
3	potassium ion import	GO:0010107	9.37	ATP12A ATP4A
4	ATP hydrolysis coupled proton transport	GO:0015991	9.32	ATP12A ATP4A
5	cellular sodium ion homeostasis	GO:0006883	9.26	ATP12A ATP4A
6	cellular potassium ion homeostasis	GO:0030007	9.16	ATP12A ATP4A
7	sodium ion export across plasma membrane	GO:0036376	8.96	ATP12A ATP4A
8	establishment or maintenance of transmembrane electrochemical gradient	GO:0010248	8.62	ATP12A ATP4A

Molecular functions related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	sodium:potassium-exchanging ATPase activity	GO:0005391	8.96	ATP12A ATP4A
2	potassium:proton exchanging ATPase activity	GO:0008900	8.62	ATP12A ATP4A

Sources

Sources for Gastric Antral Vascular Ectasia

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia